Logo
EventsWebinars

Targeting glycosylated PD-L1 to enhance patients’ anti-cancer immune response

Join us and GeneTex for this webinar on the role of PD-L1 in cancer therapy! PD-L1 is a transmembrane protein involved in the suppression of the immune response.

GeneTex webinar on the role of PD-L1 in cancer therapy
GeneTex webinar on the role of PD-L1 in cancer therapy

Date and time:
Thursday, November 19th, 2 p.m.- 3 p.m. (CET)

Speaker:
Dr. Chia-Wei Li (Assistant researcher)

Objectives:

  1. Immunity and cancers
  2. Glycosylation of programmed death-ligand 1 (PD-L1)
  3. Cancer therapies
  4. GeneTex’s featured products

Register here for the webinar